Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06467630
Other study ID # RTR+ 2023-01
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date February 9, 2024
Est. completion date December 2025

Study information

Verified date May 2024
Source Septodont
Contact CCP from the Sponsor
Phone +33 1 49 76 70 00
Email clinical-operations@septodont.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The goal of this observational study is to measure in real practice the performance and safety of RTR+Membrane, a synthetic dental membrane for guided tissue regeneration in periodontal or dental implant surgery. The main question it aims to answer is to measure the post-operative wound healing several months after surgery. Participants will be followed after their dental surgery via clinical examination and radiological and photos images.


Description:

Participants are any adult patients with one of the 3 following dental treatments to be done with RTR+Membrane: - post-extraction socket preservation, - alveolar ridge augmentation, - Guided Tissue Regeneration (GTR) during immediate implant placement. Since it is a real-life evidence study in current practice, patients will be followed at their surgery and their follow-ups. Below are listed visits and type of data collected. - V1 - Surgery: Demography, Medical history and concomitant treatments, Clinical/technical information (tooth extraction, surgery, membrane and grafting materials use), Clinical Exam, Photography, X-rays or Cone Beam Computed Tomography (CBCT) - V2 - Early follow-up (including suture removal, if needed): Clinical Exam, Questionnaire, Photography - V2bis - Early follow-up: Clinical Exam, Photography - V3 - Late follow-up: Clinical Exam, Photography, X-rays or CBCT, Questionnaire


Recruitment information / eligibility

Status Recruiting
Enrollment 90
Est. completion date December 2025
Est. primary completion date December 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years to 89 Years
Eligibility Inclusion Criteria: - Male or female adult patient - Patient with one of the 3 following dental treatments to be done with the study device: post-extraction socket preservation, alveolar ridge augmentation, or Guided Tissue Regeneration (GTR) during immediate implant placement. - Patient affiliated or beneficiary of a social security system. - Patient has signed his/her informed consent form. Exclusion Criteria: - Pregnancy or lactation - Active tissue infection at the implant site - Several dental treatments done simultaneously in non-contiguous dental zones - Heavy smoker (>10 cigarettes / day) - Patient receiving long-term corticosteroid therapy, anti-rejection drugs, bisphosphonates, head & neck radiotherapy or chemotherapy - Patient with chronic infections (such as osteomyelitis) at the surgical site - Patient with poorly controlled metabolic disorders (such as diabetes, osteomalacia, thyroid disorders) - Patient with an auto-immune disease - Patient under tutelage, vulnerable person, person without liberty, or unable to complete questionnaire independently

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Preserving alveolar bone volume after tooth extraction
Visit 1: A periodontal or dental implant surgery is done aiming to preserve alveolar bone volume after extraction Visit 2 (10 days ± 4 days) - Early post-surgery follow-up V2bis (1 month +/- 1 week) - Early post-surgery follow-up Visit 3 (5 months ± 1 month) - Late post-surgery follow-up
Alveolar crest reconstruction
Visit 1: A periodontal or dental implant surgery is done aiming to alveolar crest reconstruction Visit 2 (10 days ± 4 days) - Early post-surgery follow-up Visit 3 (5 months ± 1 month) - Late post-surgery follow-up
Covering bone defects during immediate implant placement.
Visit 1: A periodontal or dental implant surgery is done aiming to cover bone defects during immediate implant placement. Visit 2 (10 days ± 4 days) - Early post-surgery follow-up Visit 3 (3 months ± 1 month) - Late post-surgery follow-up

Locations

Country Name City State
France Hospital University of Nantes Nantes
France Private dental practice office of Dr. Alain Hoornaert Nantes
France Private dental practice office of Dr. Samer Saloum-Rouxel Nantes
France Private dental practice office of Dr. Xavier Struillou Nantes
France Private dental practice office of Dr. Edouard Lanoiselée Nozay
France Private dental practice office of Dr. Aurélien Fruchet Olonne-sur-Mer
France Private dental practice office of Dr. Hélène Le Hécho Orée d'Anjou
France Private dental practice office of Dr. Nicolas Strube Orvault
France Private dental practice office of Dr. Romain Besnier Orvault

Sponsors (1)

Lead Sponsor Collaborator
Septodont

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Post-operative wound healing measured by the Early Wound-Healing Index For all groups
The Early Wound-Healing Index (EHI) has the following best to worst scoring:
(EHI) 1: complete flap closure without fibrin line in the interproximal area. (EHI) 2: complete flap closure with fine fibrin line in the interproximal area. (EHI) 3: complete flap closure with fibrin clot in the interproximal area. (EHI) 4: incomplete flap closure with partial necrosis of the interproximal tissue. (EHI) 5: incomplete flap closure with complete necrosis of the interproximal tissue.
The EHI is evaluated at the Visit 3 (late post-surgery follow-up) for the primary outcome measure.
up to 6 months
Secondary Post-operative wound healing measured by Early Wound-Healing Index For all groups
The Early Wound-Healing Index (EHI) has the following best to worst scoring:
(EHI) 1: complete flap closure without fibrin line in the interproximal area. (EHI) 2: complete flap closure with fine fibrin line in the interproximal area. (EHI) 3: complete flap closure with fibrin clot in the interproximal area. (EHI) 4: incomplete flap closure with partial necrosis of the interproximal tissue. (EHI) 5: incomplete flap closure with complete necrosis of the interproximal tissue.
The EHI is evaluated at the Visit 2 for this secondary outcome measure.
up to 14 days
Secondary Post-operative wound healing measured by Early Wound Healing Score For all groups
The Early Wound Healing Score is from 0 (worse) to 10 (best).
The EHS is evaluated at the Visit 2 for this secondary outcome measure.
up to 14 days
Secondary Post-operative clinical exam For all groups
This is a descriptive secondary outcome measured by the investigator via the reporting of the presence or the absence of:
pain,
discomfort,
inflammation,
hematoma, redness,
swelling/suppuration,
membrane exposure,
dehiscence.
The evaluation is done at visit 2, visit 2Bis, and visit 3.
up to 6 months
Secondary Number of adverse device effects (at least possibly) related to study device For all groups up to 6 months
Secondary Oral Health-Related Quality of Life measured by the Oral Health Impact Profile (OHIP-5 items) For all groups
The 5 items of OHIP are: Difficulty chewing any foods; Painful aching in the mouth; Felt uncomfortable about the appearance of teeth; Less flavor in the food; and, Difficulty doing the usual jobs.
Score is from 0 (best) to 20 (worse). The evaluation is done at visit 2 and visit 3.
up to 6 months
Secondary Radiological measurements on CBCT Only for Post-extraction socket preservation sub-group & for Alveolar ridge augmentation sub-group
The treatment efficacy is measured via the following measures on CBCT:
A. Osseous changes in mesiodistal width of the alveolar ridge
B. Osseous changes in height of the alveolar ridge
C. Osseous changes in vestibulolingual dimension of the alveolar ridge.
These changes are evaluated from Baseline to Visit 3.
up to 6 months
Secondary Radiological measurements on retro-alveolar radios Only for Guided Tissue Regeneration (GTR) during immediate implant placement subgroup.
The treatment efficacy is measured via the following measures:
A. Distal vertical situation of the bone plateau compared to the implant by retroalveolar radiography
B. Mesial vertical situation of the bone plateau compared to the implant by retroalveolar radiography
C. Insertion Torque Value (Ncm)
These changes are evaluated from Baseline to Visit 3.
up to 4 months
See also
  Status Clinical Trial Phase
Completed NCT06139939 - Guided Bone Regeneration for Horizontal Alveolar Ridge Augmentation With Double Layer Technique N/A
Not yet recruiting NCT03840681 - Assessment of Guided Bone Regeneration in Atrophic Anterior Maxilla N/A
Completed NCT05143242 - Contour Augmentation by Means of Connective Tissue Grafting Versus Guided Bone Regeneration N/A
Not yet recruiting NCT06286605 - RCT GBR One Stages Comparing A-Oss and Autogenous Bone Versus A-Oss and LCR-A N/A
Recruiting NCT03225495 - Comparison Between Ultra-narrow Diameter Implants (2,75 mm) Without Bone Regeneration Versus Standard Diameter Implants (4,3 mm) in Combination With Bone Regeneration N/A
Recruiting NCT06295055 - Semi-rigid Shell Barrier System for Alveolar Bone Augmentation (SSBS for ABA) N/A
Not yet recruiting NCT04679766 - Evaluation of Ice Cream Cone Technique With Immediate Implant Placement in Patients With Labial Plate Dehiscence N/A
Not yet recruiting NCT06257225 - Evaluation of Horizontal Bone Gain in the Lower Posterior Partially Edentulous Patient Comparing the Stabilization of Membranes With and Without Tacs N/A
Recruiting NCT05890469 - Effect of Implant Surface Material and Topography on Bone Regeneration. N/A
Recruiting NCT04451486 - A Phase I Study of SB Cell for the Enhanced Osseointegration of Guided Bone Regeneration in Implant Surgery Phase 1